We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Quanterix has secured an emergency use authorisation (EUA) from the US Food and Drug Administration (FDA) for its Simoa SARS-CoV-2 N protein antigen test. Simoa (single molecule array
Medical diagnostic and consumer healthcare technology firm Biotricity is set to introduce a new personal heart monitor called Bioheart. The company has designed the new personal heart monitor
British medical technology firm Quanta Dialysis Technologies has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its haemodialysis system called SC+. The new system
Digital health company Everlywell has entered into a distribution agreement with life sciences company Ginkgo Bioworks on the Covid-19 antigen test. Under the deal, Everlywell will supply Access
Tidepool, a 501(c)3 nonprofit, today announced completion of its FDA submission of Tidepool Loop, an automated insulin dosing app intended for the management of type 1 diabetes. The
PerkinElmer has agreed to acquire diagnostics company Oxford Immunotec Global in a deal valued at around $591m. The acquisition is said to be implemented through a UK High
QT Imaging, developer of the QTscan, has selected Freedom Ventures B.V., as the exclusive distributor of its 3D breast imaging technology for the European, Middle Eastern and North
Pi-Cardia Ltd., a global leader in the development of non-implant, catheter-based solutions for treating heart valves, announced today successful first-in-human procedures with its ShortCut device. ShortCut is the
Spectrum Solutions has secured CE mark approval for its SDNA-2000 and SDNA-3000 saliva collection devices for IVD molecular diagnostic testing across Europe. The approval enables to integrate Spectrum
The MCM expects to quickly meet the high demand for negative pressure beds in the nation and eventually many other countries where the third wave of COVID-19 is